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Abstract
Introduction
SMA is characterised by progressive motor and respiratory muscle weakness. We aimed
to verify if in SMA children 1)each form is characterized by specific ventilatory and thoraco-
abdominal pattern(VTAp) during quiet breathing(QB); 2)VTAp is affected by salbutamol
therapy, currently suggested as standard treatment, or by the natural history(NH) of SMA;
3)the severity of global motor impairment linearly correlates with VTAp.
Materials and methods
VTAp was analysed on 32 SMA type I (SMA1,the most severe form), 51 type II (SMA2,the
moderate), 8 type III (SMA3,the mildest) and 20 healthy (HC) using opto-electronic plethys-
mography. Spirometry, cough and motor function were measured in a subgroup of patients.
Results
In SMA1, a normal ventilation is obtained in supine position by rapid and shallow breathing
with paradoxical ribcage motion. In SMA2, ventilation is within a normal range in seated
position due to an increased respiratory rate(p<0.05) with reduced tidal volume(p<0.05)
secondary to a poor contribution of pulmonary ribcage(%ΔVRC,P, p<0.001). Salbutamol
therapy had no effect on VTAp during QB(p>0.05) while tachypnea occurred in type I NH. A
linear correlation(p<0.001) was found between motor function scales and VTAp.
Conclusion
A negative or reduced %ΔVRC,P, indicative of ribcage muscle weakness, is a distinctive fea-
ture of SMA1 and SMA2 since infancy. Its quantitative assessment represents a non-inva-
sive, non-volitional index that can be obtained in all children, even uncollaborative, and
provides useful information on the action of ribcage muscles that are known to be affected
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by the disease.Low values of motor function scales indicate impairment of motor but also of
respiratory function.
Introduction
Spinal Muscular Atrophy (SMA) is characterized by degeneration of αmotoneurons in the spi-
nal cord, resulting in progressive motor and respiratory muscle weakness and paralysis[1–5].
According to severity and age of onset, clinical phenotypes have been grouped into the most
severe type I (SMA1), the moderate type II (SMA2) and the mildest type III (SMA3) forms[6–
8].
Respiratory problems are the major causes of hospitalization, morbidity and mortality in
SMA children[9]. Over the last decade, proactive management of respiratory complications
has rapidly increased, thus improving survival and quality of life.[10–14] Additionally, an
increasing number of potential therapeutic strategies are entering or have already entered clini-
cal phases[5,15,16]. Specific respiratory outcome measures are therefore needed to objectively
evaluate the effects of interventions in all SMA children.
Respiratory function can be assessed by invasive and non-invasive techniques[17–21]. Inva-
sive measurements are generally not well tolerated by children, and non-invasive techniques
should be considered. These include the measure of spirometric parameters, peak cough flow
(PCF)[22], ventilatory pattern and thoraco-abdominal contribution during spontaneous quiet
breathing at rest (QB).
Since the early childhood, in SMA1 and SMA2 spirometric indexes are reduced and show a
relatively slow rate of decline, eventually worsened by scoliosis[23–28]. Cough is inefficient
and requires assistance since the first years of life[29–31]. Both spirometry and PCFmeasure-
ment are volitional tests requiring high collaboration and therefore being consistently per-
formed since the age when the child understands the operation. On the other hand, non-
volitional measurement during QB is feasible in almost all patients, even those uncooperative.
SMA children are at risk of hypoventilation, and ventilatory support is needed to reverse the
resulting reduced arterial oxyhemoglobin saturation and microatelectasis.[14] Rapid and shal-
low breathing ensues in awake SMA2, hypothesized to be a respiratory strategy these children
adopt to minimize their work of breathing[23].
None of the above techniques or parameters provides specific information on inspiratory
ribcagemuscles (iRCM) status. This would be useful, as in SMA the phrenic motoneurons, and
consequently the diaphragm, are preserved[32], while progressive weakness affects iRCM[9].
The assessment of thoraco-abdominal contribution during QB allows to selectively study
the involvement of the different respiratory muscle groups. Thoraco-abdominal asynchrony
and reduced ribcage expansion have been reported in SMA1 and SMA2 children but only lying
supine[17–19]. In this position, the diaphragm lengthens, becoming the leading respiratory
muscle with increased tension development. In supine position, therefore, a possible deficit of
iRCM can bemasked by the action of the diaphragm. For this reason, it would be of clinical
interest to study these children also in seated position when iRCM and the diaphragm almost
equally contribute to tidal volume[33]
We therefore hypothesized that 1) the three forms of SMA are characterized by different
and specific ventilatory and thoraco-abdominal patterns during QB and 2) the rib cage contri-
bution to tidal volume provides specific information on iRCM, and is affected by posture. To
verify this, the respiratory pattern of young children affected by the three forms of SMA was
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separately described in seated and supine position and compared with healthy children. In
addition to these two main hypotheses, we also verified if 3) the breathing pattern is affected by
salbutamol therapy, being proposed to have beneficial effect on motor function and spirometry
in SMA by increasing the survivalmotorneuron transcript levels in leucocytes, and currently
suggested as standard supportive treatment for children with SMA in many neuromuscular
centres[34–36]; and 4) respiratory outcomes are linearly correlated with the severity of global
motor impairment, assessed by functionalmotor scales, as already reported for adult SMA
patients[37]. Finally, as parents of SMA1 infants are called to choose between leaving the pure
natural history of the disease to take its course or to use respiratory supports, we also investi-
gated if the breathing pattern differs between these two groups of SMA1 infants[10,11,38,39].
Materials and Methods
Subjects and clinical features
This is a prospective cross-sectional study, approved by the Research Ethics Board of the Carlo
Besta Neurological Research Institute (registration number: CE: 20/2014), on SMA children
enrolled according to the following criteria: genetically proven diagnosis of SMA; age<8 years;
absence of previous spinal surgery, acute respiratory failure, airway infections and 24-hours
mechanical ventilation dependence.
In the patient population, cough assistance device was routinely used by 57% of SMA1 and
90% of SMA2 children, nocturnal ventilation respectively by 40% (two SMA1 patients were tra-
cheostomized) and 29%, spinal bracing by 50% and 82%, and the 41% of SMA2 were on salbu-
tamol at a stable dosage from at least 12 months. Eleven (34%) SMA1 and ten (19.5%) SMA2
children had at least one hospitalization for acute respiratory illness within the previous year
(or since birth for infants) before the acquisition.
Parents of 10 SMA1 infants refused any respiratory support.
A control group of healthy children was also included.
All parents signed a written informed consent.
Motor and lung function assessment
Global motor functionwas assessed by applying the 16-item scale Children’s Hospital of Phila-
delphia Infant Test for Neuromuscular Disorders (CHOP INTEND) scale[40,41] for SMA1,
while the 33-items Hammersmith functionalmotor scale expanded (HFMSE)[42] and the
9-items Upper LimbModule (ULM) were used in SMA2 and SMA3. The HFMSE assesses
motor function (e.g. lying, rolling, sitting, crawling, attaining standing, walking, running and
jumping) in order of progressive difficulty, with higher values showing higher function abili-
ties. It incorporates 13 relevant items to eliminate the ‘‘ceiling” effect of the original scale when
applied to ambulant SMA patients. The 9 items of ULMwere specifically developed to assess
upper limb function in non-ambulant SMA patients, including young low functioning children
[42]. The total score is calculated by summing the scores of the individual items and it can
range from 0 (all activities failed) to 64, 66 and 18 (all activities achieved unaided), for the
CHOP INTEND, HFMSE and ULM respectively.Forced vital capacity (FVC), forced expiratory
volume in one second (FEV1), their ratio (FEV1/FVC) and peak cough flow (PCF) were mea-
sured (Pony FX PNT, Cosmed, Rome-Italy) when children were able to reasonably understand
and follow instructions. The criteria used to determine if the spirometry tests were performed
to an acceptable degree followed the Thoracic Society/EuropeanRespiratory Society Statement
[43]. Predicted spirometric values were calculated by applying the global lungs initiative equa-
tions for spirometry[44,45] while predicted values of PCF according to Bianchi and Baiardi
The Breath of SMA Children
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[46]. The numerosity of the percentage values was reduced compared to absolute values
because there are no prediction values for children younger than the age of 4.
Breathing pattern and thoraco-abdominal contribution during QB
The volume variations of the chest wall (ΔVCW) and its compartments, namely pulmonary
ribcage (ΔVRC,P), abdominal ribcage (ΔVRC,A) and abdomen (ΔVAB) were measured by opto-
electronic plethysmography (OEP, BTS, Milan, Italy)[47,48] during at least 5 minutes of spon-
taneous QB before in seated and then other 5 minutes in supine position with the child awake
(Brazelton stage 4)[49] while watching a cartoon (Fig 1). If the child was drowsy or slept or
cried all the time during the acquisition, and therefore intervals of QB were impossible to be
identified, he/she was excluded from the study.
The following parameters were calculated during inspiration of a 40-seconds period of QB:
respiratory rate (RR), tidal volume (VT), minute ventilation (V´E = RRVT), rapid and shallow
breathing index (RSBi = RR/VT), the percentage contribution of each compartment to VT (%
ΔVRC,P, index of iRCM action; %ΔVRC,A, index of the expansion of the appositional zone of the
diaphragm and %ΔVAB, index of diaphragmatic action) and the phase shift angle between
ΔVRC,P and ΔVAB (ϕTA). VT was calculated as the difference between body-weight normalized
ΔVCW and the total anatomic dead space body-weight normalized.[50]. The accuracy of OEP
system during quiet breathing has been previously tested by simultaneous measurements with
Fig 1. Experimental set-up for the analysis of chest wall volumes via opto-electronic
plethysmography of a SMA child in seated (top) and supine (bottom right) positions while watching
a cartoon. SMA3 and HC could sit without support and therefore 89 and 52 markers were respectively used
in seated and supine position[44,45,48,50]. SMA2 children were all wheelchair bound and in both postures a
new model was used with five horizontal rows of five markers, three rows of three markers with two additional
markers making a total of 36 (bottom left). SMA1 were analyzed only in supine position, using the 36 model
as well.
doi:10.1371/journal.pone.0165818.g001
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a spirometer in healthy adults[47,51], newborns[52] and infants[53]. In all these studies, the
discrepancy between the two measurements was always<4%. The intraclass correlation coeffi-
cient values of OEP was shown to be higher than 0.75 while the coefficient of variation less
than 10%. These parameters indicate that OEP presents adequate intra- and inter-rater reliabil-
ity[54].
Statistical analysis
Differences in anthropometric data, respiratory parameters and motor functionwere tested
applying a one-way Analysis of Variance(ANOVA) with disease as independent factor. When
normality test failed, a Kruskal-Wallis one-way ANOVA on Ranks was performed. Post-hoc
tests based on Holm–Sidak and Dunn’s methods were respectively used for parametric and
non-parametric ANOVA.
The same analysis was performed, consideringmedication or the family choice as indepen-
dent factor, to test if motor and respiratory function of SMA2 under salbutamol therapy were
different than not-treated children or if differences were present between SMA1 infants whose
parents had chosen to follow the natural history of SMA or to support ventilation.
The least-square linear regression analysis was performed to verify if motor functional scales
linearly correlated with the respiratory function parameters significantly affected by the disease.
Data are expressed as median and interquartile range (IQR). Significancewas determined
by p<0.05.
Results
Anthropometric, spirometric and cough data
One-hundred-fifteen children were enrolled and data on 111 reported. Four children were
excluded because it was not possible to obtain at least 40 seconds of QB (Fig 2).
Age was similar between SMA2, SMA3 and healthy (HC, median: 62.4, IQR: 52.5–72.0
months) children, while SMA1 were younger and characterized by lower weight (HC,
18.0,15.5–22.0 Kg) and height (HC, 114.5, 110.0–120.0 cm), as shown in Table 1.
SMA2 children showed reduced absolute spirometric and PCF values compared to SMA3
whose PCF was lower than predicted (Table 1).
Fig 2. Flow diagram of recruited children and functional tests. QB: quiet breathing; MFS: motor functional scale; S&C: spirometry and cough
tests; OEP: opto-electronic plethysmography
doi:10.1371/journal.pone.0165818.g002
The Breath of SMA Children
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Breathing pattern and thoraco-abdominal contribution during QB
SMA1 children were characterized by normal VE, greater RSBi and RR, reduced VT (Fig 3)
with negative %ΔVRC,P compensated by higher %ΔVAB leading to paradoxical thoraco-abdom-
inal motion close to complete out of phase (Fig 4). They also showed lower (p<0.001) values of
%ΔVRC,A (median: -2.1%; IQR: -8.7–3.2) compared to SMA2 (12.0%; 8.1–15.7), SMA3 (18.1%;
16.6–19.1) and HC (12.2%; 8.6–15.8).
Lying supine, SMA2 breathed like healthy peers whereas differences emerged when seated,
with normal V´E, higher RR and reduced VT resulting in rapid and shallowed breathing (Fig
5). Despite the increased%ΔVAB, VT was lower because of the reduced%ΔVRC,P (Fig 6) with %
ΔVRC,A not differing among SMA2 (15.6%; 12.2–18.5), SMA3 (21.0; 17.0–28.1) and HC
(20.3%; 16.7–23.5).
%ΔVRC,P was negative in 14 and 6 SMA2 children, respectively in supine and seated position.
No differences were found between SMA3 and HC children.
Fig 7 shows representative thoraco-abdominal volume traces for each considered group.
Effect of salbutamol therapy
In SMA2, HMFSE, ULM, FVC, FEV1, PCF, breathing pattern and thoraco-abdominal contri-
bution during QB in seated and supine position did not differ (p>0.05) between children on
salbutamol at a stable dosage from at least 12 months and untreated children.
Table 1. median and interquartile range (IQR) of anthropometric, motor function, spirometric and cough data in SMA types I (SMA1), II (SMA2)
and III (SMA3) children.
SMA1 SMA2 SMA3
median IQR median IQR median IQR
Anthropometry
n 32 51 8
age (months) 9.8 (6.2–16.0)˚ 44.8 (36.4–63.8) 64.8 (54.4–79.8)
height (cm) 72.0 (66.1–85.0) ˚ 101.8 (91.5–109.7) 120.0 (101.5–122.0)
weight (Kg) 7.6 (6.8–9.6) ˚ 14.4 (12.2–17.0) 18.5 (15.2–21.5)
Motor function assessment
n 23 34 7
CHOP INTEND (/64) 22.0 (21.0–32.5) - -
HFMSE (/66) - 16.5 (12.0–24.9)# 49.0 (45.5–55.0)
ULM (/18) - 10.0 (6.0–12.8) ### 18.0 (17.5–18.0)
Spirometry and cough measurement
n 22 5
FVC (L) - 0.55 (0.47–0.89) ### 1.34 (1.16–1.63)
FVC (%pred) - 69.4 (47.2–90.9) 94.3 (89.5–102.2)
FEV1 (L) - 0.53 (0.40–0.71) # 1.06 (1.03–1.53)
FEV1 (%pred) - 61.5 (50.7–82.9) 103.7 (91.8–105.3)
FEV1/FVC (%) - 89.6 (81.7–98.5) 93.0 (90.3–96.0)
PCF (L/min) - 97.2 (59.85–112.2) # 154.5 (116.1–216.2)
PCF (%pred) - 59.8 (43.5–70.0) # 73.3 (63.8–89.2)
˚: p<0.05 vs SMA2,SMA3 and healthy children
#, ###: p<0.05, 0.001 vs SMA3.
doi:10.1371/journal.pone.0165818.t001
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Correlation between motor and respiratory function assessments
While thoraco-abdominal measurements linearly correlated with CHOP INTEND,
HFMSE and ULM scales, the latter two also correlated with FVC, FEV1 and PCF and
VT/Kg (Table 2).
Fig 3. Box-and-whisker plot representing the median (line within the box), the IQR (length of the box), the 90th and the 10th percentiles
(whiskers above and below the box) of total ventilation (V´E, top left panel), rapid and shallow breathing index (RSBi, top right panel),
respiratory rate (bottom left panel) and tidal volume (VT, bottom right panel) in SMA types I, II, III and healthy children (SMA1, SMA2,
SMA3 and HC, respectively) at rest during spontaneous quiet breathing in supine position. ˚: p<0.05 vs SMA2, SMA3 and HC
doi:10.1371/journal.pone.0165818.g003
The Breath of SMA Children
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SMA1 infants on natural history
The age range of the SMA1 group on natural history (NH) was between 4 and 12 months. In
order to avoid bias due to age, and therefore to the evolution of the disease, 9 patients receiving
respiratory support were excluded because older than 12 months. The remaining 13 infants
receiving respiratory support showed significantly lower RR compared to the group on natural
history (IQR: 50–66 and 58–84, respectively, p = 0.041).
Discussion
In the present study the detailed description of the respiratory function in a large cohort of
young (<8 yrs), and therefore hardly cooperative, children affected by the three forms of SMA
is provided and compared. The assessment of the breathing pattern at rest was feasible, well tol-
erated and significantly different according to the severity of the disease. Our findings show
that 1) SMA1 and SMA2 are characterized by weakened inspiratory ribcagemuscles and spared
diaphragm since childhood, as confirmed by accurate measurements of percentage contribu-
tion of rib cage and abdomen to tidal volume; 2) when evaluating respiratory muscles action,
posture plays a crucial role, with ribcagemuscle weakness of SMA2 emerging only in the seated
position; 3) a 12-months stable dosage of salbutamol does not affect motor and respiratory
functions in our cohort of SMA2; 4) in children with SMA, motor function, assessed by differ-
ent disease-specific functional scales, is linearly correlated with several spirometric and respira-
tory function parameters during spontaneous QB; and 5) SMA1 children for whom the
spontaneous course of the disease was chosen were more tachypneic compared to those receiv-
ing respiratory support.
In these children, respiratory involvement differs according to the severity of the disease,
therefore, it is important to differentiate the respiratory treatment since early childhood.
SMA type I–Without any postural support, SMA1 patients can only adopt the supine posi-
tion. In this situation, without any ventilatory assistance, while awake and in stable condition,
SMA1 children are able to maintain normal levels of V´E only by adopting a rapid and shallow
breathing pattern, mostly due to high RR with a slightly reduced VT. Since RR is known to
Fig 4. Box-and-whisker plot representing the median (line within the box), the IQR (length of the box), the 90th and the 10th percentiles
(whiskers above and below the box) of pulmonary ribcage percentage contribution to tidal volume (left panel), abdominal percentage
contribution to tidal volume (middle panel) and thoraco-abdominal phase shift angle (right panel) in SMA types I, II, III and healthy children
(SMA1, SMA2, SMA3 and HC, respectively) at rest during spontaneous quiet breathing in supine position. Negative values of pulmonary ribcage
percentage contribution to tidal volume indicate paradoxical inward movement of the compartment during inspiration. Phase shift angle varies between 0,
when the two compartments are fully in phase, and -180˚ when one compartment is completely out of phase respect the other with consequent
paradoxical movement. ˚,˚˚˚: p<0.05, 0.001 vs SMA2, SMA3 and HC; **: p<0.01 vs SMA3
doi:10.1371/journal.pone.0165818.g004
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inversely correlate with age, being its variability larger in the first months of life, it is important
to understand whether the high rate of RR observed in SMA1 is either a consequence of the dis-
ease or of the youngest age. Reported reference values for RR in healthy children range from 47
breath/min respectively from 2 to 36 months of age[55–57], whereas in our population of
Fig 5. Box-and-whisker plot representing the median (line within the box), the IQR (length of the box), the 90th and the 10th percentiles
(whiskers above and below the box) of minute ventilation (V´E, top left panel), rapid and shallow breathing index (RSBi, top right panel),
respiratory rate (bottom left panel) and tidal volume (VT, bottom right panel) in SMA types II, III and healthy children (SMA2, SMA3 and HC,
respectively) at rest during spontaneous quiet breathing in seated position. *: p<0.05 vs SMA3; #, ##, ###: p<0.05, 0.01, 0.001 vs HC
doi:10.1371/journal.pone.0165818.g005
The Breath of SMA Children
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SMA1 IQR was 48–75 (Fig 2). Tachypnea, therefore, seems to be a clinical sign in SMA1, even
in the absence of respiratory infection, representing the ventilatory strategy adopted by these
children to compensate for their shallow breathing, in order to guarantee normal ventilation.
The reduced VT, in turn, is due to the inspiratory paradoxical inward movement of pulmonary
ribcage (IPIM_RC,p).
Under physiological conditions, in supine position the diaphragm adopts a more favorable
geometry, being lengthened by the abdominal content[58–60]. As a consequence, the pressure
developed and the resulting abdominal displacement is greater compared to the seated posi-
tion, even with similar levels of neural drive. This is the reason why in supine position abdomi-
nal contribution to tidal volume becomes greater than ribcage[48,61], with the latter not
showing any paradox thanks to the action of the iRCM. On the other hand, we observe a con-
sistent presence of IPIM_RCp in SMA1, suggesting that iRCM are presumably not able to con-
trast the negative pleural pressure swings generated by diaphragmatic contraction. The
presence of IPIM_RCp has at least two negative consequences. Firstly, a portion of the lung
does not expand properly during inspiration. Secondly, part of diaphragm’s work is wasted to
distort the chest wall rather than to inflate the lungs.
SMA type II—The breathing pattern of SMA2 is normal in supine, whereas differences
emerge in seated position with a rapid and shallow breathing, adopted to guarantee normal
ventilation, characterized by reduced%ΔVRC,P.
Under physiological conditions, the dependence of VT and thoraco-abdominal pattern on
posture is due to its effect on ribcage and abdominal compliances. Compared to supine, in
seated position the former increases while the latter decreases because of the tonic activity of
abdominal muscles to stabilize the trunk[62]. As a consequence, diaphragm’s contraction
results more into expanding the inferior ribcage, than in moving the abdominal viscera[63]
and the expansion of ΔΔRC,P becomes predominantly due to the contraction of iRCM[64,65].
The reduced%ΔΔRC,P, therefore, suggests that weakened iRCM are not able to fully counterbal-
ance the decrease of pleural pressure determined by the contraction of a preserved diaphragm,
also of SMA2, leading to IPIM_RCp in some cases (12% in seated, 27% in supine) and presum-
ably to the poor spirometry.
SMA type III–In our cohort of SMA3, FVC and FEV1 were within predicted values, with
slightly lower values of PCF, and normal ventilatory and thoraco-abdominal patterns. Because
Fig 6. Box-and-whisker plot representing the median (line within the box), the IQR (length of the box), the 90th and the 10th percentiles
(whiskers above and below the box) of pulmonary ribcage percentage contribution to tidal volume (left panel), abdominal percentage
contribution to tidal volume (middle panel) and thoraco-abdominal phase shift angle (right panel) in SMA types II, III and healthy children
(SMA2, SMA3 and HC, respectively) at rest during spontaneous quiet breathing in seated position. **,***: p<0.01, 0.001 vs SMA3; ###: p<0.001
vs HC
doi:10.1371/journal.pone.0165818.g006
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of the small number in this subgroup, it was not possible to distinguish between the subtypes
IIIA and IIIB, who were reported to be characterized by different respiratory features[37].
Taken together, our results confirm the general consensus that, according to the severity of
the disease, SMA causes iRCMweakness with a preserved diaphragm, with the following con-
sequences[19,23]: 1) alveolar hypoventilation, 2) poor airway clearance due to reduced cough
efficacy, 3) micro-atelectasis reducing lung compliance, 4) bell-shaped chest with sternal
depression reducing chest wall compliance, and 5) diaphragmatic fatigue secondary to the
increasedmechanical load.
%ΔVRC,P, therefore, represents a potential useful clinical outcome in SMA, that can be
obtained by OEP in all children regardless collaboration, severity level and in different pos-
tures. OEP may be particularly useful in monitoring the progression of the disease and the
effects of possible interventions and/or of newmedicinal products in young SMA children.
Conversely, active effort-dependent volume measurements, like spirometry and cough, have
two intrinsic problems for children: 1) poor availability of reliable values due to the lack of col-
laboration, and 2) absence of predicted values of children younger than the age of 4 years.
Fig 7. Representative traces of chest wall (CW, thin grey line), pulmonary ribcage (RC,p, black line) and abdominal (AB, bold grey line) volume
variations during spontaneous quiet breathing in one represented subject belonging to SMA types I, II, III and healthy children (SMA1,SMA2,
SMA3 and HC, respectively). In supine position (upper panels), the reduced tidal volume, the increased respiratory rate and the inspiratory paradoxical
indrawing of the pulmonary ribcage compensated by increasing abdominal contribution in SMA1 are evident. Only in seated position (lower panels), in
SMA2 total and compartmental volume change are reduced.
doi:10.1371/journal.pone.0165818.g007
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Our study has some limitations: 1) absence of infants in the control group to be compared
with SMA1, but normalizingVT according to body weight and correcting for the total anatomi-
cal dead space allowed to take into account the difference in body size that was shown to
remain invariant with age[19]; 2) reduced number of available motor function, spirometry and
PCF records due either to the young age of patients or to the fact that they were not acquired
close to QB analysis; 3) use of a newmodel of markers, that anyway provided ventilatory
parameters comparable with those previously measured by pneumotachography in SMA chil-
dren[19,23,56,57,66,67].
The strength of this study is that the analysis was performed in a large cohort of young SMA
children and controls during awake QB, in the positions commonly adopted in daily life, with-
out any specific requested maneuver. The study has also clinical implications and demon-
strated: 1) the importance of posture when evaluating respiratory muscle function; 2) the need
for larger prospective randomized, double-blind, placebo controlled trials to better understand
the potentiality of salbutamol on motor and respiratory functions in SMA patients (in contrast
with other works[34–36] we did not find any difference on motor and respiratory function in
SMA2-treated children); 3) the potentiality of CHOP INTEND, HFMSE and ULM scales to
predict poor respiratory outcomes, in particular the inefficient action of iRCM, although they
do not specifically assess any aspect of respiratory function; and 4) the effect of proactive respi-
ratory assistance in SMA1 infants to help reducing tachypnea. It was not possible to carry out a
similar comparison for SMA2 because in these children the respiratory management was per-
formed according to the international guidelines[11,39], and proactive and multidisciplinary
management was adopted in all patients. We believe that such respiratory care and assistance
may be the reason of the relatively limited incidence of hospitalization in SMA2 children.
Conclusions
A negative or reduced%ΔVRC,P, indicative of ribcagemuscle weakness, is a distinctive feature
of SMA1 and SMA2 since infancy. Its quantitative assessment represents a non-invasive, non-
volitional index that can be used to detect changes on the respiratory function over time and
the effects of specific interventions and/or of clinical pharmacological trials in all forms of
Table 2. Linear regression parameters between CHOP INTEND, HFMSE and ULM scales and the respiratory function parameters significantly
affected in SMA types I and II-III, respectively.
CHOP INTEND HFMSE ULM
r2 p r2 p r2 p
FVC (L) 0.530 <0.001 0.599 <0.001
FEV1 (L) 0.516 <0.001 0.568 <0.001
PCF (%pred) 0.229 0.084 0.128 0.231
PCF (L) 0.328 0.008 0.323 0.011
RR§ 0.003 0.796 0.011 0.529 0.052 0.195
RSBi/Kg§ 0.007 0.160 0.041 0.228 0.084 0.092
VT/Kg§ 0.000 0.966 0.165 0.012 0.204 0.007
ϕTA§ 0.217 0.007 0.441 <0.001 0.431 <0.001
ΔVRC,P (%VT) § 0.168 0.020 0.419 <0.001 0.407 <0.001
ΔVAB (%VT) § 0.219 0.007 0.530 <0.001 0.599 <0.001
§ acquired in supine position when correlated with CHOP INTEND and in seated position when correlated with HFMSE and ULM
The correlation coefficient (r2) quantifies the strength of the association between the variables, when p>0.05 there is no significant relationship between the
two variables.
doi:10.1371/journal.pone.0165818.t002
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SMA. Low values on SMA-specific motor function scales indicate impairment not only of
motor but also of respiratory functions.
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